BioStem Technologies, Inc. (BSEM)
3.43
-0.14
(-3.79%)
USD |
OTCM |
Jun 10, 16:00
BioStem Technologies Total Liabilities (Quarterly) : 23.21M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 23.21M |
| December 31, 2025 | 11.06M |
| September 30, 2025 | 12.38M |
| June 30, 2025 | 64.52M |
| March 31, 2025 | 101.79M |
| December 31, 2024 | 18.47M |
| September 30, 2024 | 81.37M |
| June 30, 2024 | 75.85M |
| March 31, 2024 | 39.03M |
| December 31, 2023 | 15.95M |
| September 30, 2023 | 9.340M |
| June 30, 2023 | 8.553M |
| March 31, 2023 | 7.665M |
| December 31, 2022 | 7.527M |
| September 30, 2022 | 6.910M |
| June 30, 2022 | 7.225M |
| March 31, 2022 | 6.774M |
| December 31, 2021 | 8.466M |
| September 30, 2021 | 8.540M |
| June 30, 2021 | 8.632M |
| March 31, 2021 | 8.518M |
| December 31, 2020 | 8.072M |
| September 30, 2020 | 8.355M |
| June 30, 2020 | 7.891M |
| March 31, 2020 | 7.246M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 5.972M |
| September 30, 2018 | 3.861M |
| June 30, 2018 | 2.626M |
| March 31, 2018 | 1.933M |
| December 31, 2017 | 1.598M |
| September 30, 2017 | 1.453M |
| June 30, 2017 | 1.638M |
| March 31, 2017 | 1.638M |
| December 31, 2016 | 2.257M |
| September 30, 2016 | 2.291M |
| June 30, 2016 | 1.856M |
| March 31, 2016 | 1.318M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.1424M |
| March 31, 2014 | 0.0992M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.23M |
| CorMedix, Inc. | 378.59M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
| Axsome Therapeutics, Inc. | 659.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.08M |
| Shareholders Equity (Quarterly) | 31.87M |
| Debt to Equity Ratio | 0.1029 |
| Current Ratio | 1.142 |
| Net Debt Paydown Yield | 0.33% |